• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症 COVID-19 的免疫遗传学关联

Immunogenetic Association Underlying Severe COVID-19.

作者信息

McCoy Kendall, Peterson Autumn, Tian Yun, Sang Yongming

机构信息

Department of Biology, College of Life and Physical Sciences, Tennessee State University, 3500 John A. Merritt Boulevard, Nashville, TN 37209, USA.

Department of Agricultural and Environmental Sciences, College of Agriculture, Tennessee State University, 3500 John A. Merritt Boulevard, Nashville, TN 37209, USA.

出版信息

Vaccines (Basel). 2020 Nov 20;8(4):700. doi: 10.3390/vaccines8040700.

DOI:10.3390/vaccines8040700
PMID:33233531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7711778/
Abstract

SARS-CoV2 has caused the current pandemic of new coronavirus disease 2019 (COVID-19) worldwide. Clinical outcomes of COVID-19 illness range broadly from asymptotic and mild to a life-threatening situation. This casts uncertainties for defining host determinants underlying the disease severity. Recent genetic analyses based on extensive clinical sample cohorts using genome-wide association studies (GWAS) and high throughput sequencing curation revealed genetic errors and gene loci associated with about 20% of life-threatening COVID-19 cases. Significantly, most of these critical genetic loci are enriched in two immune signaling pathways, i.e., interferon-mediated antiviral signaling and chemokine-mediated/inflammatory signaling. In line with these genetic profiling studies, the broad spectrum of COVID-19 illness could be explained by immuno-pathological regulation of these critical immunogenetic pathways through various epigenetic mechanisms, which further interconnect to other vital components such as those in the renin-angiotensin-aldosterone system (RAAS) because of its direct interaction with the virus causing COVID-19. Together, key genes unraveled by genetic profiling may provide targets for precisely early risk diagnosis and prophylactic design to relieve severe COVID-19. The confounding epigenetic mechanisms may be key to understanding the clinical broadness of COVID-19 illness.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV2)已在全球引发了2019年新型冠状病毒病(COVID-19)的大流行。COVID-19疾病的临床结果差异很大,从无症状和轻症到危及生命的情况都有。这使得确定疾病严重程度背后的宿主决定因素存在不确定性。最近基于大量临床样本队列,利用全基因组关联研究(GWAS)和高通量测序筛选进行的基因分析,揭示了与约20%危及生命的COVID-19病例相关的基因错误和基因位点。值得注意的是,这些关键基因位点大多富集于两种免疫信号通路,即干扰素介导的抗病毒信号通路和趋化因子介导的/炎症信号通路。与这些基因谱研究一致,COVID-19疾病的广泛表现可以通过这些关键免疫遗传通路通过各种表观遗传机制进行的免疫病理调节来解释,由于其与导致COVID-19的病毒直接相互作用,这种调节还进一步与肾素-血管紧张素-醛固酮系统(RAAS)等其他重要成分相互关联。总之,基因谱分析揭示的关键基因可能为精确的早期风险诊断和预防性设计提供靶点,以缓解严重的COVID-19。混杂的表观遗传机制可能是理解COVID-19疾病临床广泛性的关键。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4f0/7711778/5d1c3da06cf4/vaccines-08-00700-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4f0/7711778/c3ce053d61b3/vaccines-08-00700-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4f0/7711778/5d1c3da06cf4/vaccines-08-00700-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4f0/7711778/c3ce053d61b3/vaccines-08-00700-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4f0/7711778/5d1c3da06cf4/vaccines-08-00700-g002.jpg

相似文献

1
Immunogenetic Association Underlying Severe COVID-19.重症 COVID-19 的免疫遗传学关联
Vaccines (Basel). 2020 Nov 20;8(4):700. doi: 10.3390/vaccines8040700.
2
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).血管紧张素转化酶 2(ACE2)、严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)与 2019 冠状病毒病(COVID-19)的病理生理学。
J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10.
3
Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19.外周血全基因组 DNA 甲基化谱分析揭示与严重 COVID-19 相关的表观遗传特征。
J Leukoc Biol. 2021 Jul;110(1):21-26. doi: 10.1002/JLB.5HI0720-466R. Epub 2021 Jan 19.
4
Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review.肾素-血管紧张素-醛固酮系统抑制剂在 COVID-19 中的应用:综述。
Clinics (Sao Paulo). 2021 Apr 9;76:e2342. doi: 10.6061/clinics/2021/e2342. eCollection 2021.
5
Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity.先天免疫缺陷相关疾病对严重急性呼吸综合征冠状病毒 2 感染宿主防御和疾病发病机制的启示
Curr Opin Allergy Clin Immunol. 2021 Dec 1;21(6):515-524. doi: 10.1097/ACI.0000000000000786.
6
Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.伴有确诊的 2019 冠状病毒病(COVID-19)感染住院患者肾素-血管紧张素-醛固酮系统阻滞剂管理(麦吉尔 RAAS-COVID-19):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Feb 5;22(1):115. doi: 10.1186/s13063-021-05080-4.
7
Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation.心血管疾病患者 COVID-19 并发症增加:肾素-血管紧张素-醛固酮系统(RAAS)失调的作用。
Chem Biol Interact. 2022 Jan 5;351:109738. doi: 10.1016/j.cbi.2021.109738. Epub 2021 Nov 3.
8
A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.一项蛋白质组学全基因组遗传研究鉴定出了几个与临床相关的新冠病毒利用的宿主靶标。
Elife. 2021 Aug 17;10:e69719. doi: 10.7554/eLife.69719.
9
Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2.ACE2 调节的内分泌方面:肾素-血管紧张素-醛固酮系统、类固醇激素和 SARS-CoV-2。
J Endocrinol. 2020 Nov;247(2):R45-R62. doi: 10.1530/JOE-20-0260.
10
Association of Renin-Angiotensin-Aldosterone Inhibitors with COVID-19 Infection and Disease Severity among Individuals with Hypertension.血管紧张素转换酶抑制剂与 COVID-19 感染及高血压患者疾病严重程度的相关性。
Isr Med Assoc J. 2022 May;24(5):310-316.

引用本文的文献

1
Genetic liability to systemic inflammatory regulators is causally linked to COVID-19 diverse phenotypes: Insights from multi-omics association study and single-cell RNA sequencing analysis.全身炎症调节因子的遗传易感性与新冠病毒病的多种表型存在因果关系:多组学关联研究和单细胞RNA测序分析的见解
Medicine (Baltimore). 2025 Aug 22;104(34):e44089. doi: 10.1097/MD.0000000000044089.
2
Exploring the interplay between host genetics and acute and long COVID: A narrative review.探索宿主遗传学与急性新冠和新冠长期症状之间的相互作用:一篇叙述性综述。
Clinics (Sao Paulo). 2025 Jun 20;80:100708. doi: 10.1016/j.clinsp.2025.100708.
3
Severe COVID-19 disease is associated with genetic factors affecting plasma ACE2 receptor and CRP concentrations.

本文引用的文献

1
Epigenetic Evolution of ACE2 and IL-6 Genes: Non-Canonical Interferon-Stimulated Genes Correlate to COVID-19 Susceptibility in Vertebrates.ACE2 和 IL-6 基因的表观遗传进化:非经典干扰素刺激基因与脊椎动物对 COVID-19 的易感性相关。
Genes (Basel). 2021 Jan 25;12(2):154. doi: 10.3390/genes12020154.
2
Genetic mechanisms of critical illness in COVID-19.新型冠状病毒肺炎危重症的遗传机制。
Nature. 2021 Mar;591(7848):92-98. doi: 10.1038/s41586-020-03065-y. Epub 2020 Dec 11.
3
Human recombinant soluble ACE2 in severe COVID-19.严重新型冠状病毒肺炎中的人重组可溶性血管紧张素转换酶2
重症 COVID-19 疾病与影响血浆 ACE2 受体和 CRP 浓度的遗传因素有关。
Sci Rep. 2025 Feb 8;15(1):4708. doi: 10.1038/s41598-025-89306-4.
4
Healthcare Workers' Assessment of a Visual Triage System (VTS).医护人员对视觉分诊系统(VTS)的评估
Cureus. 2023 Dec 4;15(12):e49910. doi: 10.7759/cureus.49910. eCollection 2023 Dec.
5
Molecular Understanding of ACE-2 and HLA-Conferred Differential Susceptibility to COVID-19: Host-Directed Insights Opening New Windows in COVID-19 Therapeutics.对ACE-2和HLA赋予的COVID-19易感性差异的分子理解:宿主导向的见解为COVID-19治疗打开新窗口
J Clin Med. 2023 Apr 1;12(7):2645. doi: 10.3390/jcm12072645.
6
Severe COVID-19 multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection.严重 COVID-19 多系统炎症综合征:比较 SARS-CoV-2 感染的两种危急结局。
Eur Respir Rev. 2023 Mar 8;32(167). doi: 10.1183/16000617.0197-2022. Print 2023 Mar 31.
7
Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study.重症新型冠状病毒肺炎与α1-抗胰蛋白酶缺乏症:COVID-AATD研究
Biomedicines. 2023 Feb 10;11(2):516. doi: 10.3390/biomedicines11020516.
8
Effects of Epitranscriptomic RNA Modifications on the Catalytic Activity of the SARS-CoV-2 Replication Complex.RNA 转录后修饰对 SARS-CoV-2 复制复合物催化活性的影响。
Chembiochem. 2023 Apr 17;24(8):e202300095. doi: 10.1002/cbic.202300095. Epub 2023 Mar 22.
9
The causal relationship between circulating cytokines and critically ill COVID-19: A bidirectional Mendelian randomization analysis.循环细胞因子与危重症 COVID-19 之间的因果关系:双向孟德尔随机化分析。
J Glob Health. 2022 Feb 19;12:05010. doi: 10.7189/jogh.12.05010. eCollection 2022.
10
Association Between Genetic Predictors for C-Reactive Protein and Venous Thromboembolism With Severe Adverse Coronavirus Disease 2019 Outcomes.C反应蛋白和静脉血栓栓塞的遗传预测指标与2019年冠状病毒病严重不良结局之间的关联。
Crit Care Explor. 2021 Dec 20;3(12):e0602. doi: 10.1097/CCE.0000000000000602. eCollection 2021 Dec.
Lancet Respir Med. 2020 Nov;8(11):1154-1158. doi: 10.1016/S2213-2600(20)30418-5. Epub 2020 Sep 24.
4
Repurposing anticancer drugs for the management of COVID-19.重新利用抗癌药物来治疗新冠肺炎。
Eur J Cancer. 2020 Dec;141:40-61. doi: 10.1016/j.ejca.2020.09.014. Epub 2020 Sep 22.
5
COVID-19: Infection or Autoimmunity.COVID-19:感染还是自身免疫?
Front Immunol. 2020 Sep 11;11:2055. doi: 10.3389/fimmu.2020.02055. eCollection 2020.
6
Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".减轻 COVID-19 中高危人群冠状病毒诱导的免疫功能障碍:训练免疫、卡介苗和“新老朋友”。
Front Immunol. 2020 Sep 4;11:2059. doi: 10.3389/fimmu.2020.02059. eCollection 2020.
7
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.急性 COVID-19 患者中针对 SARS-CoV-2 的抗原特异性适应性免疫反应,及其与年龄和疾病严重程度的关联。
Cell. 2020 Nov 12;183(4):996-1012.e19. doi: 10.1016/j.cell.2020.09.038. Epub 2020 Sep 16.
8
The major genetic risk factor for severe COVID-19 is inherited from Neanderthals.严重 COVID-19 的主要遗传风险因素来自尼安德特人。
Nature. 2020 Nov;587(7835):610-612. doi: 10.1038/s41586-020-2818-3. Epub 2020 Sep 30.
9
Artificial intelligence in COVID-19 drug repurposing.人工智能在新冠病毒药物再利用中的应用。
Lancet Digit Health. 2020 Dec;2(12):e667-e676. doi: 10.1016/S2589-7500(20)30192-8. Epub 2020 Sep 18.
10
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.COVID-19 危重症患者体内针对 I 型干扰素的自身抗体。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4585. Epub 2020 Sep 24.